HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
-6.39%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$21.5M
AUM Growth
+$21.5M
Cap. Flow
+$2.19M
Cap. Flow %
10.18%
Top 10 Hldgs %
100%
Holding
18
New
2
Increased
3
Reduced
–
Closed
2

Top Buys

1
GNLN icon
Greenlane Holdings
GNLN
$2.4M
2
PFE icon
Pfizer
PFE
$2.17M
3
GILD icon
Gilead Sciences
GILD
$1.35M
4
GSK icon
GSK
GSK
$800K
5
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$620K

Top Sells

1
AGN
Allergan plc
AGN
$4.39M
2
ATRS
Antares Pharma, Inc.
ATRS
$758K

Sector Composition

1 Healthcare 83.05%
2 Consumer Staples 11.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GSK icon
1
GSK
GSK
$79.9B
$4.8M 9.01% 120,000 +20,000 +20% +$800K
GILD icon
2
Gilead Sciences
GILD
$140B
$4.73M 8.87% 70,000 +20,000 +40% +$1.35M
TYME
3
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.65M 4.98% 2,175,000 – –
GNLN icon
4
Greenlane Holdings
GNLN
$4.71M
$2.4M 4.5% +250,000 New +$2.4M
PFE icon
5
Pfizer
PFE
$141B
$2.17M 4.06% +50,000 New +$2.17M
VKTX icon
6
Viking Therapeutics
VKTX
$3.04B
$2.08M 3.89% 250,000 – –
NVLN
7
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.4M 2.63% 1,800,000 – –
ADMS
8
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$1.24M 2.33% 200,000 +100,000 +100% +$620K
ABBV icon
9
AbbVie
ABBV
$372B
– – 0 – –
CRON
10
Cronos Group
CRON
$996M
– – 0 – –
CVS icon
11
CVS Health
CVS
$92.8B
– – 0 – –
JNJ icon
12
Johnson & Johnson
JNJ
$427B
– – 0 – –
LGND icon
13
Ligand Pharmaceuticals
LGND
$3.15B
– – 0 – –
SPY icon
14
SPDR S&P 500 ETF Trust
SPY
$658B
– – 0 – –
VIXY icon
15
ProShares VIX Short-Term Futures ETF
VIXY
$87.1M
– – 0 – –
GWPH
16
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– – 0 – –
AGN
17
DELISTED
Allergan plc
AGN
– – -30,000 Closed -$4.39M
ATRS
18
DELISTED
Antares Pharma, Inc.
ATRS
– – -250,000 Closed -$758K